Monograph
N06AB03 - Fluoxetine |
Not porphyrinogenic |
NP |
Rationale
Fluoxetine is a MI complexing agent in rat liver, but not necessarily in human liver. Not porphyrinogenic in chick hepatocyte culture. Repeated clinical experience points to non-porphyrinogenicity. Several references consider it safe.
Chemical description
Serotonine reuptake inhibitor. Strong CYP 2D6- and CYP 3A4 -inhibitor of long duration. Australian list: safe EPI-list: safe South African list: use with care French list: use Thunell; patient inquiry; clinical observation: tolerated (n=7) H.Bonkovsky:
IPNet drug reports
Uneventful use reported in 41 patients with acute porphyria.
Similar drugs
Tradenames and packages
From some sources, we get a list of packages (United Kingdom, Ireland, Estonia).
Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway).
What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names
are the searchable terms. The gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors.
We strive to improve it continuously.
Netherlands
Belgium
United Kingdom
Denmark
Norway
Poland
Luxembourg
Iceland
Finland
Latvia
Serbia
